JP4369246B2 - 眼用超小型基準デバイス及び使用方法 - Google Patents
眼用超小型基準デバイス及び使用方法 Download PDFInfo
- Publication number
- JP4369246B2 JP4369246B2 JP2003580991A JP2003580991A JP4369246B2 JP 4369246 B2 JP4369246 B2 JP 4369246B2 JP 2003580991 A JP2003580991 A JP 2003580991A JP 2003580991 A JP2003580991 A JP 2003580991A JP 4369246 B2 JP4369246 B2 JP 4369246B2
- Authority
- JP
- Japan
- Prior art keywords
- eye
- reference device
- contrast
- ultra
- imaging
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title description 10
- 238000003384 imaging method Methods 0.000 claims description 16
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical group [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 15
- 229910052737 gold Inorganic materials 0.000 claims description 12
- 239000010931 gold Substances 0.000 claims description 12
- 238000001356 surgical procedure Methods 0.000 claims description 11
- 210000003786 sclera Anatomy 0.000 claims description 9
- 239000000853 adhesive Substances 0.000 claims description 4
- 230000001070 adhesive effect Effects 0.000 claims description 4
- 238000012634 optical imaging Methods 0.000 claims description 4
- 239000002872 contrast media Substances 0.000 claims description 3
- 230000000149 penetrating effect Effects 0.000 claims description 3
- 239000006260 foam Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 description 15
- 239000000463 material Substances 0.000 description 12
- 210000003128 head Anatomy 0.000 description 7
- 229910001000 nickel titanium Inorganic materials 0.000 description 5
- 229910001220 stainless steel Inorganic materials 0.000 description 5
- 239000010935 stainless steel Substances 0.000 description 5
- 208000010412 Glaucoma Diseases 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- 239000007943 implant Substances 0.000 description 4
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 238000002604 ultrasonography Methods 0.000 description 4
- 238000012285 ultrasound imaging Methods 0.000 description 4
- 230000004410 intraocular pressure Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 2
- 239000004642 Polyimide Substances 0.000 description 2
- 210000003484 anatomy Anatomy 0.000 description 2
- 210000004087 cornea Anatomy 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920001721 polyimide Polymers 0.000 description 2
- 238000011477 surgical intervention Methods 0.000 description 2
- 239000013077 target material Substances 0.000 description 2
- 210000001585 trabecular meshwork Anatomy 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 2
- 229910052721 tungsten Inorganic materials 0.000 description 2
- 239000010937 tungsten Substances 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 239000004821 Contact adhesive Substances 0.000 description 1
- 229920001651 Cyanoacrylate Polymers 0.000 description 1
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 1
- 102000029749 Microtubule Human genes 0.000 description 1
- 108091022875 Microtubule Proteins 0.000 description 1
- 208000022873 Ocular disease Diseases 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 239000004830 Super Glue Substances 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- HZEWFHLRYVTOIW-UHFFFAOYSA-N [Ti].[Ni] Chemical compound [Ti].[Ni] HZEWFHLRYVTOIW-UHFFFAOYSA-N 0.000 description 1
- 239000003522 acrylic cement Substances 0.000 description 1
- 210000002159 anterior chamber Anatomy 0.000 description 1
- 210000001742 aqueous humor Anatomy 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000004240 ciliary body Anatomy 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 239000004053 dental implant Substances 0.000 description 1
- 210000002555 descemet membrane Anatomy 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000005553 drilling Methods 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- FGBJXOREULPLGL-UHFFFAOYSA-N ethyl cyanoacrylate Chemical compound CCOC(=O)C(=C)C#N FGBJXOREULPLGL-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 108010025899 gelatin film Proteins 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000696 magnetic material Substances 0.000 description 1
- 210000004688 microtubule Anatomy 0.000 description 1
- 238000002324 minimally invasive surgery Methods 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 229910052594 sapphire Inorganic materials 0.000 description 1
- 239000010980 sapphire Substances 0.000 description 1
- 229910010271 silicon carbide Inorganic materials 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 238000003325 tomography Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
- A61B2090/3925—Markers, e.g. radio-opaque or breast lesions markers ultrasonic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
- A61B2090/3937—Visible markers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
- A61B2090/3954—Markers, e.g. radio-opaque or breast lesions markers magnetic, e.g. NMR or MRI
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
- A61B2090/3983—Reference marker arrangements for use with image guided surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
- A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
Landscapes
- Health & Medical Sciences (AREA)
- Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Pathology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Eye Examination Apparatus (AREA)
Description
国際公開第01/10324号パンフレット、「脊椎用基準インプラント及び方法」
国際公開第01/10302号パンフレット、「生物分解性脊椎用基準インプラント及び方法」
国際公開第99/26540号パンフレット、「外科用テンプレート集成体並びに歯科インプラントを穴開け及び装着するための方法」
米国特許第6096048号明細書、「非侵襲性で再取付け可能な頭蓋用基準マーカーシステム」
Claims (7)
- 高解像度画像化とともに用いる、眼用超小型基準デバイスであって、前記画像化によって、眼内の対象となる組織に対するデバイスの位置を与えることにより外科手術用に眼の表面上に基準点を確立するためのデバイスにおいて、
50から250μmの直径を有するコントラストターゲットと、眼の強膜に前記コントラストターゲットを固定するためのスパイクとを備えることを特徴とする超小型基準デバイス。 - 高解像度画像化とともに用いる、眼用超小型基準デバイスであって、前記画像化によって、眼内の対象となる組織に対するデバイスの位置を与えることにより外科手術用に眼の表面上に基準点を確立するためのデバイスにおいて、
50から250μmの直径を有するコントラストターゲットと、眼の表面上に前記コントラストターゲットを配置するための接着性または粘着性の物質とを備えることを特徴とする超小型基準デバイス。 - 前記スパイクが、強膜を貫通せずに目の表面に固定できるように、250から750μmの長さを有することを特徴とする請求項1記載の超小型基準デバイス。
- 前記コントラストターゲットが、金球であることを特徴とする請求項1から3のいずれか1項記載の超小型基準デバイス。
- 前記コントラストターゲットが、コントラスト材を含む1以上のスペースを有するハウジングを有することを特徴とする請求項1から3のいずれか1項記載の超小型基準デバイス。
- 前記コントラスト材が、超音波画像化のためのガスまたは光画像化のための染料を含むことを特徴とする請求項5記載の超小型基準デバイス。
- 前記コントラストターゲットが、多くの高コントラストターゲットを組み込んだ泡を含むことを特徴とする請求項5記載の超小型基準デバイス。
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36685202P | 2002-03-22 | 2002-03-22 | |
| PCT/US2003/008866 WO2003083630A2 (en) | 2002-03-22 | 2003-03-21 | Ophthalmic microfiducial device and method for use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005520666A JP2005520666A (ja) | 2005-07-14 |
| JP4369246B2 true JP4369246B2 (ja) | 2009-11-18 |
Family
ID=28675290
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003580991A Expired - Fee Related JP4369246B2 (ja) | 2002-03-22 | 2003-03-21 | 眼用超小型基準デバイス及び使用方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20050165413A1 (ja) |
| EP (1) | EP1487388A2 (ja) |
| JP (1) | JP4369246B2 (ja) |
| AU (1) | AU2003220476A1 (ja) |
| CA (1) | CA2478914A1 (ja) |
| WO (1) | WO2003083630A2 (ja) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009020994A2 (en) * | 2007-08-06 | 2009-02-12 | Doheny Eye Institute | Ultrasound and microbubbles in ocular diagnostics and therapies |
| WO2012118965A1 (en) * | 2011-03-01 | 2012-09-07 | Jeremy Schwartz | Deployable marker and method for deployment |
| US10010447B2 (en) | 2013-12-18 | 2018-07-03 | Novartis Ag | Systems and methods for subretinal delivery of therapeutic agents |
| EP3270765B1 (en) | 2015-03-20 | 2020-05-06 | Glaukos Corporation | Gonioscopic devices |
| US10674906B2 (en) | 2017-02-24 | 2020-06-09 | Glaukos Corporation | Gonioscopes |
| USD833008S1 (en) | 2017-02-27 | 2018-11-06 | Glaukos Corporation | Gonioscope |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4097081A (en) * | 1977-07-14 | 1978-06-27 | England Robert C | Device for inserting and removing contact lenses |
| US4991579A (en) * | 1987-11-10 | 1991-02-12 | Allen George S | Method and apparatus for providing related images over time of a portion of the anatomy using fiducial implants |
| DE3800076A1 (de) * | 1988-01-05 | 1989-07-20 | Preussner Paul Rolf Dr Dr | Markierungstraeger fuer nachfuehreinrichtungen zur korrektur von augenbewegungen |
| US5423829A (en) * | 1993-11-03 | 1995-06-13 | Target Therapeutics, Inc. | Electrolytically severable joint for endovascular embolic devices |
| US6096048A (en) * | 1994-04-20 | 2000-08-01 | Howard, Iii; Matthew A. | Noninvasive, reattachable skull fiducial marker system |
| DE69633074T2 (de) * | 1995-05-14 | 2004-12-30 | Optonol Ltd. | Intraokulares implantat, einführgerät sowie implantierungsverfahren |
| US5782764A (en) * | 1995-11-07 | 1998-07-21 | Iti Medical Technologies, Inc. | Fiber composite invasive medical instruments and methods for use in interventional imaging procedures |
| US6120460A (en) * | 1996-09-04 | 2000-09-19 | Abreu; Marcio Marc | Method and apparatus for signal acquisition, processing and transmission for evaluation of bodily functions |
| US20030032879A1 (en) * | 1997-07-07 | 2003-02-13 | Steven Quay | Microbubble formation using ultrasound |
| US6786899B1 (en) * | 1998-07-21 | 2004-09-07 | Ming Lai | Eye tracking employing a retro-reflective disk |
| DE10014479A1 (de) * | 2000-03-23 | 2001-10-04 | Technolas Gmbh | Iriserkennung und -nachführung zum Behandeln optischer Ungleichmäßigkeiten des Auges |
| US6397850B1 (en) * | 2000-02-09 | 2002-06-04 | Scimed Life Systems Inc | Dual-mode apparatus and method for detection of embolic device detachment |
| WO2001097696A1 (en) * | 2000-06-19 | 2001-12-27 | Image-Guided Neurologics, Inc. | System and method of minimally-invasive exovascular aneurysm treatment |
| US6602272B2 (en) * | 2000-11-02 | 2003-08-05 | Advanced Cardiovascular Systems, Inc. | Devices configured from heat shaped, strain hardened nickel-titanium |
| AU2002258754B2 (en) * | 2001-04-07 | 2006-08-17 | Glaukos Corporation | Glaucoma stent and methods thereof for glaucoma treatment |
| US6579282B2 (en) * | 2001-04-25 | 2003-06-17 | 20/10 Perfect Vision Optische Geraete Gmbh | Device and method for creating a corneal reference for an eyetracker |
-
2003
- 2003-03-21 JP JP2003580991A patent/JP4369246B2/ja not_active Expired - Fee Related
- 2003-03-21 US US10/507,943 patent/US20050165413A1/en not_active Abandoned
- 2003-03-21 EP EP03716785A patent/EP1487388A2/en not_active Withdrawn
- 2003-03-21 AU AU2003220476A patent/AU2003220476A1/en not_active Abandoned
- 2003-03-21 CA CA002478914A patent/CA2478914A1/en not_active Abandoned
- 2003-03-21 WO PCT/US2003/008866 patent/WO2003083630A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003083630A2 (en) | 2003-10-09 |
| AU2003220476A1 (en) | 2003-10-13 |
| JP2005520666A (ja) | 2005-07-14 |
| WO2003083630A3 (en) | 2003-11-27 |
| CA2478914A1 (en) | 2003-09-09 |
| EP1487388A2 (en) | 2004-12-22 |
| US20050165413A1 (en) | 2005-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4303116B2 (ja) | 眼科マイクロサージャリー装置 | |
| ES2249316T3 (es) | Tratamiento de patologias oculares. | |
| US20220031507A1 (en) | Lacrimal implant detection | |
| US10485701B2 (en) | Devices and methods for glaucoma treatment | |
| US7431710B2 (en) | Ocular implants with anchors and methods thereof | |
| US9301875B2 (en) | Ocular disorder treatment implants with multiple opening | |
| JP2012196481A (ja) | 房水排出の外科的強化のための装置 | |
| JP2001517486A (ja) | 目の網膜下腔内に接近するための装置 | |
| JP2013509245A (ja) | 眼球治療装置及び方法 | |
| JP4369246B2 (ja) | 眼用超小型基準デバイス及び使用方法 | |
| JP4872081B2 (ja) | 硝子体手術用カニューラ | |
| Hall | Video Program |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060320 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20081224 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090323 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090330 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090422 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090430 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090624 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20090728 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20090827 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120904 Year of fee payment: 3 |
|
| LAPS | Cancellation because of no payment of annual fees |